‹ All stocks
Korro Bio
KRRO · NASDAQ · Healthcare
$9.71
▼ $0.20 (-2.02%)
Day range
$9.47 – $10.27
Year range
$5.20 – $55.89
Open
$9.93
Previous close
$9.91
Market cap
$96.65M
Volume (24h)
$88.8K
Volume (52w)
$862.02K
Performance
7D
▲ 2.10%
1M
▼ -28.13%
3M
▼ -32.99%
6M
▼ -27.86%
1Y
▼ -77.78%
YTD
▲ 20.62%
3Y
▼ -35.27%
5Y
▼ -97.13%
All-time
▼ -98.58%
Key statistics
P/E ratio
-0.97
EPS (TTM)
$-10.00
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
10.0M
About Korro Bio
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1156.42 | 0.49% |
JNJ Johnson & Johnson |
$254.52 | -0.58% |
ABBV AbbVie |
$262.04 | 0.29% |
MRK Merck & Co. |
$139.70 | -2.76% |
UNH UnitedHealth Group Incorp… |
$371.61 | -0.19% |